Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Neurogene Inc. (NGNE) Schedule 13G/A reports beneficial ownership as of September 30, 2026, by Samsara BioCapital, L.P. of 1,804,197 shares (9.0%), Samsara Opportunity Fund, L.P. of 150,000 shares (0.7%), and Srinivas Akkaraju of 1,954,197 shares (9.7%).
The reported positions overlap: Akkaraju and the entities’ general partners share voting and dispositive power over fund-held securities, so the amounts are not additive. Samsara BioCapital, L.P.’s position includes 1,717,127 common shares and pre-funded warrants immediately exercisable for up to 87,070 common shares. The percentages are based on 20,011,382 common shares outstanding as of August 7, 2026, with the warrants counted for Samsara BioCapital, Samsara GP and Akkaraju. The reporting persons expressly disclaim status as a group.
Samsara BioCapital, L.P. beneficial ownership1,804,197 sharesAs of September 30, 2026; 9.0% of the class
Samsara Opportunity Fund, L.P. beneficial ownership150,000 sharesAs of September 30, 2026; 0.7% of the class
Srinivas Akkaraju beneficial ownership1,954,197 sharesAs of September 30, 2026; 9.7% of the class
Samsara BioCapital, L.P. ownership percentage9.0%As of September 30, 2026
Samsara Opportunity Fund, L.P. ownership percentage0.7%As of September 30, 2026
Srinivas Akkaraju ownership percentage9.7%As of September 30, 2026
Shares issuable under pre-funded warrantsUp to 87,070 sharesImmediately exercisable; included in Samsara BioCapital, L.P.’s reported beneficial ownership
Common shares outstanding20,011,382 sharesAs of August 7, 2026; basis for the reported ownership percentages
Key Terms
beneficial ownership, Pre-Funded Warrants, shared voting power, shared dispositive power
4 terms
beneficial ownershipfinancial
"aggregate number of shares of common stock ... beneficially owned"
Beneficial ownership means the person or entity that actually enjoys the benefits of owning shares or other assets — such as receiving dividends, voting rights, or price gains — even if the legal title is held in another name. For investors it matters because knowing who truly controls and profits from a company reveals who can influence decisions, exposes potential conflicts of interest or hidden concentration of power, and affects transparency and risk in the stock.
Pre-funded warrants are financial instruments that give investors the right to purchase a company's stock at a set price, but with most or all of the purchase price paid upfront. They function like a coupon or gift card for stock, allowing investors to buy shares later at a fixed price, which can be beneficial if they want to avoid future price increases. This makes them important for investors seeking flexibility and certainty in their investment plans.
shared voting powertechnical
"Shared Voting Power 1,804,197.00"
Shared voting power occurs when two or more parties jointly have the right to vote or decide how a block of company shares is cast, like co-owners who must agree before moving a piece of furniture. Investors care because who controls voting rights affects board elections, major corporate decisions and takeover outcomes, and shared control can alter regulatory disclosures and the practical influence any holder has over a company’s direction and value.
shared dispositive powertechnical
"Shared Dispositive Power 1,804,197.00"
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
How many NGNE shares did Samsara BioCapital report owning?
Samsara BioCapital, L.P. reported beneficial ownership of 1,804,197 shares as of September 30, 2026. That total includes 1,717,127 common shares and pre-funded warrants immediately exercisable for up to 87,070 common shares.
How much Neurogene stock did Srinivas Akkaraju beneficially own?
Srinivas Akkaraju reported beneficial ownership of 1,954,197 shares, or 9.7%, as of September 30, 2026. The filing states that he shares voting and dispositive power over securities held by Samsara BioCapital, L.P. and Samsara Opportunity Fund, L.P.
What share count did the NGNE ownership percentages use?
The reported percentages were based on 20,011,382 shares of Neurogene common stock outstanding as of August 7, 2026. The calculation gives effect to pre-funded warrants for Samsara BioCapital, L.P., Samsara BioCapital GP, LLC and Srinivas Akkaraju.
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 13G
UNDER THE SECURITIES EXCHANGE ACT OF 1934
(Amendment No. 2)
Neurogene Inc.
(Name of Issuer)
Common Stock, $0.000001 par value per share
(Title of Class of Securities)
64135M105
(CUSIP Number)
09/30/2026
(Date of Event Which Requires Filing of this Statement)
Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)
schemaVersion:
SCHEDULE 13G
CUSIP Number(s):
64135M105
1
Names of Reporting Persons
Samsara BioCapital, L.P.
2
Check the appropriate box if a member of a Group (see instructions)
(a)
(b)
3
Sec Use Only
4
Citizenship or Place of Organization
DELAWARE
Number of Shares Beneficially Owned by Each Reporting Person With:
5
Sole Voting Power
0.00
6
Shared Voting Power
1,804,197.00
7
Sole Dispositive Power
0.00
8
Shared Dispositive Power
1,804,197.00
9
Aggregate Amount Beneficially Owned by Each Reporting Person
1,804,197.00
10
Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)
11
Percent of class represented by amount in row (9)
9.0 %
12
Type of Reporting Person (See Instructions)
PN
SCHEDULE 13G
CUSIP Number(s):
64135M105
1
Names of Reporting Persons
Samsara BioCapital GP, LLC
2
Check the appropriate box if a member of a Group (see instructions)
(a)
(b)
3
Sec Use Only
4
Citizenship or Place of Organization
DELAWARE
Number of Shares Beneficially Owned by Each Reporting Person With:
5
Sole Voting Power
0.00
6
Shared Voting Power
1,804,197.00
7
Sole Dispositive Power
0.00
8
Shared Dispositive Power
1,804,197.00
9
Aggregate Amount Beneficially Owned by Each Reporting Person
1,804,197.00
10
Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)
11
Percent of class represented by amount in row (9)
9.0 %
12
Type of Reporting Person (See Instructions)
OO
SCHEDULE 13G
CUSIP Number(s):
64135M105
1
Names of Reporting Persons
Samsara Opportunity Fund, L.P.
2
Check the appropriate box if a member of a Group (see instructions)
(a)
(b)
3
Sec Use Only
4
Citizenship or Place of Organization
DELAWARE
Number of Shares Beneficially Owned by Each Reporting Person With:
5
Sole Voting Power
0.00
6
Shared Voting Power
150,000.00
7
Sole Dispositive Power
0.00
8
Shared Dispositive Power
150,000.00
9
Aggregate Amount Beneficially Owned by Each Reporting Person
150,000.00
10
Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)
11
Percent of class represented by amount in row (9)
0.7 %
12
Type of Reporting Person (See Instructions)
PN
SCHEDULE 13G
CUSIP Number(s):
64135M105
1
Names of Reporting Persons
Samsara Opportunity Fund GP, LLC
2
Check the appropriate box if a member of a Group (see instructions)
(a)
(b)
3
Sec Use Only
4
Citizenship or Place of Organization
DELAWARE
Number of Shares Beneficially Owned by Each Reporting Person With:
5
Sole Voting Power
0.00
6
Shared Voting Power
150,000.00
7
Sole Dispositive Power
0.00
8
Shared Dispositive Power
150,000.00
9
Aggregate Amount Beneficially Owned by Each Reporting Person
150,000.00
10
Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)
11
Percent of class represented by amount in row (9)
0.7 %
12
Type of Reporting Person (See Instructions)
OO
SCHEDULE 13G
CUSIP Number(s):
64135M105
1
Names of Reporting Persons
Srinivas Akkaraju
2
Check the appropriate box if a member of a Group (see instructions)
(a)
(b)
3
Sec Use Only
4
Citizenship or Place of Organization
UNITED STATES
Number of Shares Beneficially Owned by Each Reporting Person With:
5
Sole Voting Power
0.00
6
Shared Voting Power
1,954,197.00
7
Sole Dispositive Power
0.00
8
Shared Dispositive Power
1,954,197.00
9
Aggregate Amount Beneficially Owned by Each Reporting Person
1,954,197.00
10
Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)
11
Percent of class represented by amount in row (9)
9.7 %
12
Type of Reporting Person (See Instructions)
IN
SCHEDULE 13G
Item 1.
(a)
Name of issuer:
Neurogene Inc.
(b)
Address of issuer's principal executive offices:
535 W 24th Street, 5th Floor, New York, NY, 10011.
Item 2.
(a)
Name of person filing:
The names of the persons filing this report (collectively, the "Reporting Persons") are:
Samsara BioCapital, L.P. ("Samsara LP")
Samsara BioCapital GP, LLC ("Samsara GP")
Samsara Opportunity Fund, L.P. ("Samsara Opportunity Fund")
Samsara Opportunity Fund GP, LLC ("Samsara Opportunity GP")
Srinivas Akkaraju ("Dr. Akkaraju")
The Reporting Persons expressly disclaim status as a "group" for purposes of this Schedule 13G/A.
(b)
Address or principal business office or, if none, residence:
All of the entities were organized in Delaware; Dr. Akkaraju is a United States citizen.
(d)
Title of class of securities:
Common Stock, $0.000001 par value per share
(e)
CUSIP No.:
64135M105
Item 3.
If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:
(a)
Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o);
(b)
Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c);
(c)
Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c);
(d)
Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8);
(e)
An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E);
(f)
An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F);
(g)
A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);
(h)
A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
(i)
A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
(j)
A non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J). If filing as a non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J),
please specify the type of institution:
(k)
Group, in accordance with Rule 240.13d-1(b)(1)(ii)(K).
Item 4.
Ownership
(a)
Amount beneficially owned:
Row 9 of each Reporting Person's cover page to this Schedule 13G/A sets forth the aggregate number of shares of common stock of the Issuer beneficially owned by such Reporting Person as of September 30, 2026 and is incorporated by reference.
The Reporting Persons' beneficial ownership of the Issuer's securities includes: (i) 1,717,127 shares of common stock and pre-funded warrants ("Pre-Funded Warrants") immediately exercisable for up to 87,070 shares of common stock directly held by Samsara LP and (ii) 150,000 shares of common stock directly held by Samsara Opportunity Fund.
Samsara GP is the sole general partner of Samsara LP and Dr. Akkaraju is the managing member of Samsara GP. Each of Samsara GP and Dr. Akkaraju possesses power to direct the voting and disposition of the securities held by Samsara LP.
Samsara Opportunity GP is the sole general partner of Samsara Opportunity Fund and Dr. Akkaraju is the managing member of Samsara Opportunity GP. Each of Samsara Opportunity GP and Dr. Akkaraju possesses power to direct the voting and disposition of the securities held by Samsara Opportunity Fund.
(b)
Percent of class:
Row 11 of each Reporting Person's cover page to this Schedule 13G/A sets forth the percentage of shares of common stock of the Issuer beneficially owned by such Reporting Person as of September 30, 2026 and is incorporated by reference. The percentage set forth in each row 11 is based upon 20,011,382 shares of common stock outstanding as of August 7, 2026, as reported in the Issuer's Quarterly Report on Form 10-Q filed with the Securities and Exchange Commission (the "SEC") on August 11, 2026 and, with respect to Samsara LP, Samsara GP and Dr. Akkaraju, giving effect to Pre-Funded Warrants.
(c)
Number of shares as to which the person has:
(i) Sole power to vote or to direct the vote:
Row 5 of each Reporting Person's cover page to this Schedule 13G/A sets forth the sole power to vote or to direct the vote of securities of the Issuer beneficially owned by such Reporting Person as of September 30, 2026 and is incorporated by reference.
(ii) Shared power to vote or to direct the vote:
Row 6 of each Reporting Person's cover page to this Schedule 13G/A sets forth the shared power to vote or to direct the vote of securities of the Issuer beneficially owned by such Reporting Person as of September 30, 2026 and is incorporated by reference.
(iii) Sole power to dispose or to direct the disposition of:
Row 7 of each Reporting Person's cover page to this Schedule 13G/A sets forth the shared power to vote or to direct the vote of securities of the Issuer beneficially owned by such Reporting Person as of September 30, 2026 and is incorporated by reference.
(iv) Shared power to dispose or to direct the disposition of:
Row 8 of each Reporting Person's cover page to this Schedule 13G/A sets forth the shared power to vote or to direct the vote of securities of the Issuer beneficially owned by such Reporting Person as of September 30, 2026 and is incorporated by reference.
Item 5.
Ownership of 5 Percent or Less of a Class.
Not Applicable
Item 6.
Ownership of more than 5 Percent on Behalf of Another Person.
Not Applicable
Item 7.
Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.
Not Applicable
Item 8.
Identification and Classification of Members of the Group.
Not Applicable
Item 9.
Notice of Dissolution of Group.
Not Applicable
Item 10.
Certifications:
By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under § 240.14a-11.
SIGNATURE
After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.
Samsara BioCapital, L.P.
Signature:
/s/ Srinivas Akkaraju
Name/Title:
By Samsara BioCapital GP, LLC, its General Partner, By Srinivas Akkaraju, Managing Member
Date:
11/16/2026
Samsara BioCapital GP, LLC
Signature:
/s/ Srinivas Akkaraju
Name/Title:
By Srinivas Akkaraju, Managing Member
Date:
11/16/2026
Samsara Opportunity Fund, L.P.
Signature:
/s/ Srinivas Akkaraju
Name/Title:
By Samsara Opportunity Fund GP, LLC, its General Partner, By Srinivas Akkaraju, Managing Member